These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18821520)

  • 1. [Asthma and COPD - dosing recommendations at beginning and end of treatment].
    Grunze M; Petermann W
    Ther Umsch; 2008 Oct; 65(10):607-11. PubMed ID: 18821520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationale.
    Magnussen H; Watz H; Kirsten A; Decramer M; Dahl R; Calverley PM; Towse L; Finnigan H; Tetzlaff K; Disse B
    Respir Med; 2014 Apr; 108(4):593-9. PubMed ID: 24477080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of salmeterol/fluticasone via single versus separate inhalers on exacerbations in severe/very severe COPD.
    Hagedorn C; Kässner F; Banik N; Ntampakas P; Fielder K
    Respir Med; 2013 Apr; 107(4):542-9. PubMed ID: 23337300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus document on the overlap phenotype COPD-asthma in COPD.
    Soler-Cataluña JJ; Cosío B; Izquierdo JL; López-Campos JL; Marín JM; Agüero R; Baloira A; Carrizo S; Esteban C; Galdiz JB; González MC; Miravitlles M; Monsó E; Montemayor T; Morera J; Ortega F; Peces-Barba G; Puente L; Rodríguez JM; Sala E; Sauleda J; Soriano JB; Viejo JL
    Arch Bronconeumol; 2012 Sep; 48(9):331-7. PubMed ID: 22341911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Are there any advantages of a fixed combination in the treatment of asthma with respect to safety and tolerability?].
    Virchow C
    Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S376-80. PubMed ID: 19941240
    [No Abstract]   [Full Text] [Related]  

  • 7. Managing symptoms and exacerbations in pediatric asthma.
    Verberne AA
    Pediatr Pulmonol Suppl; 1997 Sep; 15():46-50. PubMed ID: 9316102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of an acute exacerbation of asthma and COPD].
    Leuppi JD; Ott SR
    Ther Umsch; 2014 May; 71(5):289-93. PubMed ID: 24794339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adrenal insufficiency during inhaled corticosteroid treatment in a child with asthma].
    Bjerre JV; Bender L; Naeraa RW; Rix M
    Ugeskr Laeger; 2008 Jun; 170(24):2161. PubMed ID: 18565305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination of beta-1 agonist and corticosteroid is advantageous not only in asthma. COPD patients spared exacerbations].
    MMW Fortschr Med; 2002 Oct; 144(44):55. PubMed ID: 12494604
    [No Abstract]   [Full Text] [Related]  

  • 11. [Do fixed combinations increase effectiveness in asthma bronchiale?].
    Vogelmeier C
    Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S372-5. PubMed ID: 19941239
    [No Abstract]   [Full Text] [Related]  

  • 12. [Modern management of asthma].
    Haasler I; Korn S; Buhl R; Taube C
    MMW Fortschr Med; 2009 Nov; 151(47):38, 40-2; quiz 43. PubMed ID: 20037978
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fluticasone propionate in children and infants with asthma].
    Marchac V; Foussier V; Devillier P; Le Bourgeois M; Polak M
    Arch Pediatr; 2007 Apr; 14(4):376-87. PubMed ID: 17289359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary diseases in the elderly. Problems of pharmacotherapy].
    Ukena D
    Internist (Berl); 2003 Aug; 44(8):995-1002. PubMed ID: 14671814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finding the correct inhaled corticosteroid dose in asthma.
    Graft DF
    Postgrad Med; 2005 May; 117(5):21-4. PubMed ID: 15948364
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial.
    Nuijsink M; Hop WC; Sterk PJ; Duiverman EJ; de Jongste JC
    Eur Respir J; 2007 Sep; 30(3):457-66. PubMed ID: 17537770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vilanterol trifenatate, a novel inhaled long-acting beta2 adrenoceptor agonist, is well tolerated in healthy subjects and demonstrates prolonged bronchodilation in subjects with asthma and COPD.
    Kempsford R; Norris V; Siederer S
    Pulm Pharmacol Ther; 2013 Apr; 26(2):256-64. PubMed ID: 23232038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma.
    Shapiro G; Lumry W; Wolfe J; Given J; White MV; Woodring A; Baitinger L; House K; Prillaman B; Shah T
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):527-34. PubMed ID: 10673196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal.
    in't Veen JC; Smits HH; Hiemstra PS; Zwinderman AE; Sterk PJ; Bel EH
    Am J Respir Crit Care Med; 1999 Jul; 160(1):93-9. PubMed ID: 10390385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD.
    Kuna P; Jenkins M; O'Brien CD; Fahy WA
    Respir Med; 2012 Apr; 106(4):531-9. PubMed ID: 22197578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.